Answers are grounded in this paper and cite their sources.
The effects of the antimycotic agent ketoconazole on steroid biosynthesis in adrenal cells was investigated in monolayer cultures of functional mouse adrenal cortex tumors. Ketoconazole inhibits ACTH-stimulated steroidogenesis to below non-stimulated levels at concentrations of 1.0 μg/ml or higher. Half maximal inhibition occurs at a concentration of 0.3 μg/ml. These drug levels are in the therapeutic range achieved by oral administration in human subjects. The inhibitory effects of 3.3 μg/ml or less of ketoconazole are totally reversible within the first hour after removal of the agent. Exposure of the cultures to high concentrations of ketoconazole for periods of 24–48 hours is not toxic to the cells, with a resumption of steroidogenic activity within several hours after its removal. Cyclic AMP-stimulated steroidogenesis is also inhibited by this agent, but it has no effect on ACTH-stimulated cAMP production in these cultures. Ketoconazole is an even more potent inhibitor of 11β hydroxylation in these cells. In mitochondrial fractions of normal rat adrenal cortex, ketoconazole inhibits both isocitrate and NADPH-supported 11β hydroxylation. These data indicate that ketoconazole directly inhibits 11β hydroxylase activity and may inhibit steroidogenesis by similarly affecting cholesterol side-chain cleavage activity.
No takes yet. Share an insight, caveat, or question.
Jerome Kowal (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: